Bg pattern

FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

famotidine cinfa 40 mg film-coated tablets EFG

Read the package leaflet carefully before starting to take this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is famotidine cinfa and what is it used for.
  2. What you need to know before taking famotidine cinfa.
  3. How to take famotidine cinfa.
  4. Possible side effects.
  5. Storage of famotidine cinfa.
  6. Contents of the pack and further information.

1. What is famotidine cinfa and what is it used for

famotidine cinfa is a medication that belongs to the group of drugs called H2 receptor antagonists or H2 blockers. These medications are used to treat diseases associated with stomach acid production.

famotidine cinfa is indicated for:

  • Treatment and relapse of duodenal and gastric ulcers.
  • Treatment of Zollinger-Ellison syndrome.
  • Treatment of heartburn and acid reflux.
  • Treatment of esophageal inflammation (reflux esophagitis).
  • Prevention of reflux esophagitis (irritation and inflammation of the esophagus).
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking famotidine cinfa

Do not take famotidina cinfa

  • If you are allergic to famotidine or any other component of this medication (listed in section 6).
  • If you are allergic to other H2 receptor antagonists.

If you are unsure whether you should take famotidine, consult your doctor.

Warnings and precautions

Before starting treatment, your doctor should rule out the presence of more serious diseases. If your doctor has not ruled out the presence of gastric neoplasia before starting treatment with famotidine, relief of gastric ulcer symptoms during treatment does not exclude the presence of a malignant ulcer.

Consult your doctor or pharmacist before starting to take famotidine cinfa and in the following cases:

  • If you have moderate or severe kidney or liver disease. Adverse reactions on the central nervous system have been reported in patients with moderate or severe renal insufficiency. Your doctor will indicate the lowest administration frequency or the lowest dose you should take.
  • If you are an elderly person, as you may have renal insufficiency.

If you have been taking famotidine for a long time, your doctor will probably perform regular check-ups. During visits to your doctor, you should inform them of any new or unusual symptoms or circumstances.

Children

The safety and efficacy of famotidine cinfa have not been established in the pediatric population.

Elderly

Consult your doctor for dose selection, and it may be useful to monitor kidney function. Patients over 65 years of age only require dose adjustment in case of moderate or severe renal insufficiency.

Other medications and famotidine cinfa

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

  • Calcium carbonate, when used to treat high blood phosphorus levels (hyperphosphatemia) in patients on dialysis.
  • Famotidine may decrease the effect of the oral suspension of posaconazole (a medication used to prevent and treat certain fungal infections).
  • Famotidine may decrease the effect of dasatinib, erlotinib, gefitinib, or pazopanib (medications used to treat cancer).

Taking famotidine cinfa with food and drinks

Famotidine does not alter its absorption when administered with meals.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medication.

Pregnancy

Treatment with famotidine is not recommended during pregnancy. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Breastfeeding

Famotidine is excreted in human milk. Breastfeeding mothers should discontinue treatment with famotidine or stop breastfeeding.

Driving and using machines

Although no effects are expected, if dizziness occurs, do not drive or use hazardous machinery.

Interference with laboratory tests

If you are going to undergo any diagnostic tests, inform your doctor that you are using this medication, as it may alter the results.

famotidine cinfa contains sodium

This medication contains less than 1 mmol of sodium (23 mg) per tablet; it is essentially "sodium-free".

3. How to take famotidine cinfa

Follow the administration instructions of this medication indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again. Remember to take your medication.

Your doctor will prescribe the appropriate dose and for how long, depending on your condition. Take only the amount prescribed by your doctor.

Treatment of duodenal ulcer

The recommended dose is 1 tablet (40 mg of famotidine) at night. It can also be administered as half a tablet (20 mg of famotidine) every 12 hours. Treatment should be maintained for 4 to 8 weeks.

Treatment of gastric ulcer(benign)

The recommended dose is 1 tablet (40 mg of famotidine) at night. Treatment should be maintained for 4 to 8 weeks.

Maintenance treatment of duodenal or gastric ulcer

The recommended dose to prevent the recurrence of peptic ulcers is half a tablet (20 mg of famotidine) administered at night. Your doctor will indicate how long you should take the medication.

Treatment of gastroesophageal reflux disease (GERD)

The recommended dose is half a tablet (20 mg of famotidine) twice a day. If there is no improvement after 4-8 weeks, consult your doctor.

Healing of ulcer associated with gastroesophageal reflux

The recommended dose is 1 tablet (40 mg of famotidine) twice a day. If there is no improvement after 4-8 weeks, consult your doctor.

Zollinger-Ellison syndrome

Treatment usually starts with a dose of half a tablet (20 mg of famotidine) every 6 hours. Your doctor will then adjust the dose according to the needs of each patient.

Dose adjustment in patients with moderate or severe renal insufficiency

Your doctor will decide if a dose adjustment is necessary, either by reducing it by half or increasing the time between doses to 36-48 hours, depending on your response.

Elderly patients only require dose adjustment in case of renal insufficiency.

If you think the effect of famotidine is too strong or too weak, inform your doctor or pharmacist.

Method of administration

Swallow the tablet whole with a little water. Your doctor will indicate how many tablets to take per day and for how long.

The score line is only for breaking the tablet if you find it difficult to swallow it whole.

If you take more famotidine cinfa than you should

Adverse reactions in cases of overdose are similar to those found in normal clinical experience.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.

If you forget to take famotidine cinfa

If you forget to take a dose, take it as soon as possible unless the time for the next dose is near. In this case, skip the missed dose and take the next tablets as usual. Do not take a double dose to make up for missed doses.

If you stop taking famotidine cinfa

Do not stop treatment abruptly or prematurely, as symptoms may worsen. Discontinuation of treatment should always be gradual and according to your doctor's instructions to avoid relapse.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone experiences them.

Common side effects (may affect up to 1 in 10 people)

  • Nervous system disorders: headache, dizziness.
  • Gastrointestinal disorders: constipation, diarrhea.

Uncommon side effects (may affect up to 1 in 100 people)

  • General disorders and administration site conditions: persistent loss of appetite, fatigue.
  • Gastrointestinal disorders: nausea, vomiting, abdominal discomfort or distension (inflammation of the abdomen), dry mouth, excess gas.
  • Skin and subcutaneous tissue disorders: rash, pruritus (itching or skin irritation).
  • Musculoskeletal and connective tissue disorders: joint pain, muscle cramps.
  • Psychiatric disorders: reversible mental disorders including depression, anxiety disorders, agitation, confusion, and hallucinations.

Rare side effects (may affect up to 1 in 1,000 people)

  • General disorders and administration site conditions: anaphylaxis (unusual or exaggerated allergic reaction), angioedema (severe allergic reaction with inflammation of the face, lips, tongue, throat, and possibly limbs, with difficulty swallowing or breathing).
  • Skin and subcutaneous tissue disorders: urticaria (skin patches).
  • Hepatobiliary disorders: cholestatic jaundice (yellowing of the skin).

Very rare side effects (may affect up to 1 in 10,000 people)

  • Skin and subcutaneous tissue disorders: toxic epidermal necrolysis (skin peeling) and hair loss.
  • Investigations: abnormalities in liver enzymes.

Reporting of side effects

If you experience any of the side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of famotidine cinfa

Keep this medication out of the sight and reach of children.

Do not store above 30°C.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Medications should not be disposed of via wastewater or household waste. Place the packaging and any unused medication in the SIGRE collection point at your pharmacy. If in doubt, consult your pharmacist on how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and further information

Composition of famotidine cinfa

  • The active ingredient is famotidine. Each film-coated tablet contains 40 mg of famotidine.
  • The other ingredients are:
  • Core of the tablet: croscarmellose sodium, talc, microcrystalline cellulose, and magnesium stearate.
  • Coating of the tablet: yellow iron oxide (E-172), red iron oxide (E-172), and Opadry-Y-1-7000 (titanium dioxide (E-171), hypromellose, and macrogol 400).

Appearance of the product and pack contents

Orange-brown, cylindrical, biconvex, film-coated tablets, scored on one side and with the code "FA40" on the other side.

They are presented in PVC/Aluminum blisters. Each pack contains 10, 14, or 28 film-coated tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Laboratorios Cinfa, S.A.

Carretera Olaz-Chipi, 10. Polígono Industrial Areta.

31620 Huarte (Navarra) - Spain

Date of the last revision of this package leaflet:August 2023

Detailed information on this medication is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es

You can access detailed and updated information on this medication by scanning the QR code included in the package leaflet and packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/63317/P_63317.html

QR code to: https://cima.aemps.es/cima/dochtml/p/63317/P_63317.html

Online doctors for FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS

Discuss questions about FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (2)
Doctor

Svetlana Kolomeeva

Cardiology 18 years exp.

Dr. Svetlana Kolomeeva is a general practitioner and internal medicine doctor providing online consultations for adults. She helps patients manage acute symptoms, chronic conditions, and preventive care. Her clinical focus includes cardiovascular health, hypertension control, and managing symptoms like fatigue, weakness, sleep issues, and overall low energy.

Patients commonly seek her help for:

  • High blood pressure, headaches, dizziness, swelling, palpitations.
  • Diagnosis and management of hypertension, arrhythmias, and tachycardia.
  • Metabolic syndrome, excess weight, high cholesterol.
  • Chronic fatigue, insomnia, poor concentration, anxiety.
  • Respiratory symptoms: colds, flu, sore throat, cough, fever.
  • Digestive issues: heartburn, bloating, constipation, IBS symptoms.
  • Chronic conditions: diabetes, thyroid disorders.
  • Interpretation of lab tests and medical reports, therapy adjustment.
  • Second opinion and decision-making support.
  • Cardiovascular disease prevention and metabolic risk reduction.
  • Long-term follow-up and dynamic health monitoring.

Dr Kolomeeva combines clinical expertise with personalised care. She clearly explains diagnoses, guides patients through symptoms and treatment options, and provides actionable plans. Her consultations are designed not only to address current complaints but also to stabilise chronic conditions and prevent future complications. She supports patients through every stage of care – from first symptoms to ongoing health management.

Camera Book a video appointment
€55
5.0 (2)
Doctor

Alexander Nazarchuk

Allergology 7 years exp.

Dr. Alexander Nazarchuk is a physician specialising in allergology and internal medicine. He provides online consultations for adults, following the principles of evidence-based medicine — no outdated treatments or unnecessary tests, with clear explanations and a personalised approach. He helps patients with a wide range of allergic and therapeutic conditions, from common day-to-day complaints to complex cases involving allergies, gastrointestinal issues, cardiovascular concerns, respiratory symptoms, and more.

You can consult Dr. Nazarchuk for:

  • Test interpretation and guidance on diagnostic plans.
  • Allergic rhinitis, hay fever, bronchial asthma (including severe cases).
  • Food and drug allergies, skin rashes, angioedema.
  • Atopic dermatitis, urticaria, contact allergies.
  • Allergen-specific immunotherapy (AIT) – initiation and ongoing management.
  • Abdominal pain, bloating, changes in bowel habits, nausea, heartburn.
  • High blood pressure and adjustment of baseline antihypertensive therapy.
  • Hyperlipidaemia and elevated cholesterol.
  • Cough, nasal congestion, fever, sore throat.
  • Anaemia, including iron deficiency and related conditions.
  • Other issues related to allergology and internal medicine.

During consultations, Dr. Nazarchuk takes a thorough, structured approach — analysing symptoms, identifying potential causes, and helping patients make informed decisions. Whether treatment, further investigation, or monitoring is needed, he explains each step clearly so you understand your health and how best to manage it.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS?
FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS?
The active ingredient in FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS is famotidine. This information helps identify medicines with the same composition but different brand names.
How much does FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS is around 2.5 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS?
FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS is manufactured by Laboratorios Cinfa S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FAMOTIDINE CINFA 40 mg FILM-COATED TABLETS?
Other medicines with the same active substance (famotidine) include FAMOTIDINE ARISTO 20 mg TABLETS, FAMOTIDINE ARISTO 40 mg TABLETS, FAMOTIDINE CINFA 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media